ListarArtículos, capítulos, libros...UCO por tema "Variant histology"
Mostrando ítems 1-2 de 2
-
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
(MDPI, 2021)A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the ... -
T1 bladder carcinoma with variant histology: pathological features and clinical significance
(Springer, 2022)The aim of the study was to stratify high-grade T1 (HGT1) bladder urothelial carcinoma into risk categories based on the presence of variant histology when compared to conventional urothelial carcinoma. The clinicopathological ...